Federated Learning to Accelerate Medical Research
Owkin announces a new collaboration with Institut Pasteur on COVID-19 and Coronaviruses Future Vaccines.
This collaboration will focus on developing a new machine learning model capable of identifying COVID-19, and more generally, any coronaviruses, protein sequences (as known as epitopes) with high immunogenic potential that could be used for peptide-based future vaccines.
Our mission at Owkin is to use machine learning to develop better drugs for patients.
Patients from around the world suffer from complex diseases and a staggering variety of symptoms. However, they share one thing in common:
Patients have a need for faster development of safer and more effective therapies.
Owkin’s mission is to empower researchers in hospitals, universities, and pharmaceutical companies to:
- understand why drug efficacy varies from patient to patient,
- enhance the drug development process, and
- identify the best drug for the right patient to improve treatment outcomes.
Therefore, Owkin has created a unique research platform, and a portfolio of AI models and solutions.
Owkin Loop is the foundation of Owkin’s research platform: it connects medical researchers with high-quality datasets from leading academic research centers around the world. Owkin Loop is powered by the two main components of Owkin’s Software Stack: Owkin Studio, our machine learning platform, and Owkin Connect, our federated learning framework. Owkin medical research collaborations are in Oncology, Immunology and Cardiovascular diseases.